Bayer Shering Pharma Applies For iPS Patent With Japan Patent Office
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Bayer Shering Pharma AG has submitted patent applications for its induced pluripotent stem cell manufacturing method with the Japan Patent Office, the first foreign entity to seek intellectual property rights protection for an iPS method after one filed by Kyoto University Professor Shinya Yamanaka, according to Bayer's patent filing released by JPO Dec. 25, 2008